Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

Abstract

This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy. © 2002 by the American Academy of Child and Adolescent Psychiatry.